PARATEK PHARMACEUTICALS INC's ticker is PRTK and the CUSIP is 699374302. A total of 93 filers reported holding PARATEK PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 3.64 and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $4,812,000 | +58.4% | 312,491 | +33.9% | 0.00% | – |
Q3 2016 | $3,037,000 | +54.6% | 233,401 | +65.3% | 0.00% | – |
Q2 2016 | $1,964,000 | -0.2% | 141,176 | +8.8% | 0.00% | – |
Q1 2016 | $1,968,000 | -20.8% | 129,733 | -0.9% | 0.00% | – |
Q4 2015 | $2,484,000 | +4.2% | 130,961 | +4.3% | 0.00% | – |
Q3 2015 | $2,385,000 | +4.3% | 125,535 | +41.5% | 0.00% | – |
Q2 2015 | $2,286,000 | +652.0% | 88,708 | +1024.7% | 0.00% | – |
Q4 2014 | $304,000 | – | 7,887 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Omega Fund Management, LLC | 2,138,872 | $55,119,000 | 27.83% |
Abingworth LLP | 1,301,413 | $33,524,000 | 15.22% |
Roumell Asset Management, LLC | 207,703 | $5,353,000 | 9.43% |
GREAT POINT PARTNERS LLC | 415,338 | $10,703,000 | 4.17% |
Aisling Capital LLC | 682,680 | $17,593,000 | 2.62% |
Broadfin Capital, LLC | 530,283 | $13,665,000 | 0.73% |
Baupost Group | 1,544,498 | $39,802,000 | 0.66% |
Tekla Capital Management LLC | 691,000 | $17,807,000 | 0.64% |
GENERAL AMERICAN INVESTORS CO INC | 277,076 | $7,140,000 | 0.59% |
Lombard Odier Asset Management (USA) Corp | 140,000 | $3,607,000 | 0.26% |